MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

Search

AdaptHealth Corp

Geschlossen

BrancheGesundheitswesen

10.14 -0.78

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

10.08

Max

10.22

Schlüsselkennzahlen

By Trading Economics

Einkommen

6.6M

22M

Verkäufe

20M

820M

KGV

Branchendurchschnitt

18.709

78.892

EPS

0.233

Gewinnspanne

2.737

Angestellte

10,500

EBITDA

-12M

171M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+33.37% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

164M

1.4B

Vorheriger Eröffnungskurs

10.92

Vorheriger Schlusskurs

10.14

Nachrichtenstimmung

By Acuity

43%

57%

134 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

AdaptHealth Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

29. Dez. 2025, 22:03 UTC

Wichtige Markttreiber

Mining Stocks Slip Near the End of Stellar Year

29. Dez. 2025, 15:57 UTC

Wichtige Markttreiber

Praxis Shares Rise on Ulixacaltamide Breakthrough Designation

29. Dez. 2025, 23:43 UTC

Market Talk

Nikkei May Decline; Yen in Focus -- Market Talk

29. Dez. 2025, 23:38 UTC

Akquisitionen, Fusionen, Übernahmen

Manus: Will Continue to Operate From Singapore

29. Dez. 2025, 23:38 UTC

Akquisitionen, Fusionen, Übernahmen

Manus: Will Continue to Sell, Operate Product Subscription Service Through App, Website

29. Dez. 2025, 23:37 UTC

Akquisitionen, Fusionen, Übernahmen

Meta Platforms: Will Integrate Manus Service Into Products

29. Dez. 2025, 23:36 UTC

Akquisitionen, Fusionen, Übernahmen

Meta Platforms: Will Continue to Operate, Sell Manus Service

29. Dez. 2025, 23:36 UTC

Akquisitionen, Fusionen, Übernahmen

Meta Platforms: Manus's Talent to Join Team to Deliver General-Purpose Agents Across Consumer, Business Products

29. Dez. 2025, 23:35 UTC

Akquisitionen, Fusionen, Übernahmen

Manus to Join Meta Platforms

29. Dez. 2025, 21:33 UTC

Akquisitionen, Fusionen, Übernahmen

Origin: Raise Values Kraken at US$8.65 Billion

29. Dez. 2025, 21:33 UTC

Akquisitionen, Fusionen, Übernahmen

Origin: Octopus Targeting Kraken Separation by Mid 2026

29. Dez. 2025, 21:31 UTC

Akquisitionen, Fusionen, Übernahmen

BlueScope: Rezoning Will Allow for Range of Commercial, Industrial Development Uses

29. Dez. 2025, 21:31 UTC

Akquisitionen, Fusionen, Übernahmen

BlueScope Also Says Land Adjacent to Port Kembla Steelworks Rezoned to Special Purpose

29. Dez. 2025, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

Origin's Kraken Stake to Remain at 22.7%

29. Dez. 2025, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

Origin Will Continue to Hold Its 22.7% Interest in Octopus

29. Dez. 2025, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

BlueScope: Guidance Reflects Sustained Strength of Operating Performance in Recent Months

29. Dez. 2025, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

Origin: Additional Interest Offsets Dilution From Raise

29. Dez. 2025, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

BlueScope Doesn't Expect Material Impact on 1H Guidance Range

29. Dez. 2025, 21:29 UTC

Akquisitionen, Fusionen, Übernahmen

Origin Waiving Australia Exclusivity to Kraken in Exchange for Additional 1.5% Equity Interest

29. Dez. 2025, 21:29 UTC

Akquisitionen, Fusionen, Übernahmen

BlueScope Expects to Complete Property Sale for A$76 Million Consideration

29. Dez. 2025, 21:29 UTC

Akquisitionen, Fusionen, Übernahmen

BlueScope Expects to Complete Property Sale in 2H of FY 2026

29. Dez. 2025, 21:28 UTC

Akquisitionen, Fusionen, Übernahmen

BlueScope: Selling Residentially Zoned Land in West Dapto to Large Homebuilder

29. Dez. 2025, 21:28 UTC

Akquisitionen, Fusionen, Übernahmen

Origin: Kraken's Raise Paves Way for Separation From Octopus Energy

29. Dez. 2025, 21:28 UTC

Akquisitionen, Fusionen, Übernahmen

Origin: Kraken to Raise Total US$1 Billion From New, Existing Investors

29. Dez. 2025, 21:28 UTC

Akquisitionen, Fusionen, Übernahmen

BlueScope Steel Exchanges Contracts for Sale of 33 Hectares of Land in West Dapto

29. Dez. 2025, 21:27 UTC

Akquisitionen, Fusionen, Übernahmen

Origin Energy to Invest US$140M in Kraken's Standalone Equity Raise

29. Dez. 2025, 20:22 UTC

Market Talk

Oil Rebounds As Russia-Ukraine War Seen Continuing -- Market Talk

29. Dez. 2025, 20:14 UTC

Market Talk

U.S. Natural Gas Futures Rise As Front Month Expires -- Market Talk

29. Dez. 2025, 20:02 UTC

Akquisitionen, Fusionen, Übernahmen

Union Pacific--Norfolk Southern Merger Targets Trucking Market Share -- Barrons.com

29. Dez. 2025, 17:36 UTC

Market Talk

U.S. Natural Gas Inventories Swing to Deficit Vs. 5-Year Average -- Market Talk

Peer-Vergleich

Kursveränderung

AdaptHealth Corp Prognose

Kursziel

By TipRanks

33.37% Vorteil

12-Monats-Prognose

Durchschnitt 13.67 USD  33.37%

Hoch 15 USD

Tief 13 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für AdaptHealth Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

3 ratings

3

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

7.95 / 8.505Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Strong Bearish Evidence

Langfristig

Strong Bearish Evidence

Stimmung

By Acuity

134 / 374 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über AdaptHealth Corp

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
help-icon Live chat